Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Aimmune Therapeutics, Inc. | aimt-ex322_7.htm |
| EX-32.1 - EX-32.1 - Aimmune Therapeutics, Inc. | aimt-ex321_19.htm |
| EX-31.2 - EX-31.2 - Aimmune Therapeutics, Inc. | aimt-ex312_8.htm |
| EX-31.1 - EX-31.1 - Aimmune Therapeutics, Inc. | aimt-ex311_6.htm |
| EX-23.1 - EX-23.1 - Aimmune Therapeutics, Inc. | aimt-ex231_18.htm |
| EX-10.8 - EX-10.8 - Aimmune Therapeutics, Inc. | aimt-ex108_347.htm |
| EX-10.2D - EX-10.2D - Aimmune Therapeutics, Inc. | aimt-ex102d_111.htm |
| EX-4.7 - EX-4.7 - Aimmune Therapeutics, Inc. | aimt-ex47_705.htm |
| 10-K - 10-K - Aimmune Therapeutics, Inc. | aimt-10k_20191231.htm |
Exhibit 21.1
List of Subsidiaries of Aimmune Therapeutics, Inc.
|
Subsidiary |
|
Jurisdiction of Incorporation or Organization |
|
Aimmune Therapeutics UK Limited |
|
United Kingdom |
|
Aimmune Therapeutics (Bermuda) Ltd. |
|
Bermuda |
|
Aimmune Therapeutics Netherlands Coöperatief U.A. |
|
Netherlands |
|
Aimmune Therapeutics Netherlands B.V. |
|
Netherlands |
|
Aimmune Therapeutics Ireland Limited |
|
Ireland |
|
Aimmune Therapeutics Germany GmbH |
|
Germany |